SCHEMBL35612

SCHEMBL35612

C=C(C)C(=O)OCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.51
THRB P10828 1/20 0.44
POLB P06746 1/20 0.40
APEX1 P27695 1/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL395578 0.98 TSHR (0.50) TSHRTHRBPOLBAPEX1HTT
SCHEMBL9301854 0.95 TSHR (0.54) TSHRTHRBPOLBAPEX1HTT
SCHEMBL18784855 0.94 TSHR (0.46) TSHRTHRBPOLBAPEX1HTT
SCHEMBL9764018 0.94 TSHR (0.46) TSHRTHRBPOLBAPEX1HTT
SCHEMBL19239960 0.94 TSHR (0.50) TSHRTHRBPOLBAPEX1HTT
SCHEMBL5202786 0.92 TSHR (0.45) TSHRTHRBPOLBAPEX1HTT
SCHEMBL13334671 0.92 TSHR (0.47) TSHRTHRBPOLBAPEX1HTT
SCHEMBL27039068 0.92 TSHR (0.47) TSHRTHRBPOLBAPEX1HTT
SCHEMBL4883019 0.91 TSHR (0.46) TSHRTHRBPOLBAPEX1HTT
SCHEMBL5575866 0.91 TSHR (0.44) TSHRTHRBPOLBAPEX1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1699 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600820-B2 Photocurable composition with high silicon content CANON KABUSHIKI KAISHA (JP) 2026-04-14 US claimed
EP-4689269-A1 SILICONE - (METH)ACRYLATE COPOLYMER EMULSION AND PREPARATION THEREOF AND USE OF THE EMULSION TO IMPART OIL REPELLENCY TO TEXTILES Dow Silicones Corporation (US) 2026-02-11 EP claimed
US-20250368802-A1 PHOTOCURABLE COMPOSITION WITH HIGH SILICON CONTENT AND HIGH STABILITY CANON KK (JP) 2025-12-04 US claimed
EP-4384560-B1 SILICONE-(METH)ACRYLATE COPOLYMER EMULSION FORMULATION FOR TEXTILE TREATMENT DOW SILICONES CORP (US) 2025-11-05 EP claimed
WO-2025090189-A1 SILICONE – (METH)ACRYLATE COPOLYMER EMULSION AND PREPARATION THEREOF AND USE OF THE EMULSION TO IMPART OIL REPELLENCY TO TEXTILES DOW SILICONES CORPORATION (US) 2025-05-01 WO claimed
EP-4526381-A1 SILICONE HYDROGEL CONTACT LENSES Interojo Inc. (KR) 2025-03-26 EP claimed
US-20240199816-A1 PHOTOCURABLE COMPOSITION WITH HIGH SILICON CONTENT CANON KABUSHIKI KAISHA (JP) 2024-06-20 US claimed
WO-2024123531-A1 PHOTOCURABLE COMPOSITION WITH HIGH SILICON CONTENT CANON KABUSHIKI KAISHA (JP) 2024-06-13 WO claimed
US-20240159938-A1 Compositions for Ophthalmologic Devices JOHNSON & JOHNSON VISION CARE, INC. 2024-05-16 US claimed
WO-2023224184-A1 SILICONE HYDROGEL CONTACT LENSES INTEROJO INC. (KR) 2023-11-23 WO claimed
US-5962548-A SOFT CONTACT LENSES JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1999-10-05 US claimed
EP-0940693-A2 Soft contact lenses Johnson & Johnson Vision Products, Inc. (US) 1999-09-08 EP claimed
US-5770669-A Silcone-containing polymer having oxygen permeability suitable for ophalmic applications CIBA VISION CORPORATION (US) 1998-06-23 US claimed
EP-0796448-A1 SILICONE-CONTAINING POLYMER SUITABLE FOR OPHTHALMIC APPLICATIONS Novartis AG (CH) 1997-09-24 EP claimed
WO-1996018122-A1 SILICONE-CONTAINING POLYMER SUITABLE FOR OPHTHALMIC APPLICATIONS NOVARTIS AG (CH) 1996-06-13 WO claimed
EP-0277555-B1 COPOLYMERS WITH 0-NITROCARBINOL ESTER GROUPS, AND PROCESS FOR PREPARING TWO-LAYER RESISTS AND SEMICONDUCTOR DEVICES BASF Aktiengesellschaft (DE) 1992-04-08 EP claimed
US-5023159-A Encapsulated electrophotographic toner compositions XEROX CORPORATION (US) 1991-06-11 US claimed
US-4988788-A Room temperature-curable coating composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 1991-01-29 US claimed
US-4808682-A BLEND WITH OLEFINICALLY UNSATURATED SILICON COMPOUND BASF AKTIENGESELLSCHAFT (DE) 1989-02-28 US claimed
EP-0277555-A2 Copolymers with 0-nitrocarbinol ester groups, and process for preparing two-layer resists and semiconductor devices BASF Aktiengesellschaft (DE) 1988-08-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600820-B2 Photocurable composition with high silicon content BIRC2, ACP1, IRS1 TSHR 4173/4885THRB 4666/4885POLB 3409/4885
US-20240159938-A1 Compositions for Ophthalmologic Devices PDE6D, CRYAB, PDE6H TSHR 3951/4885THRB 4153/4885POLB 4031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.